BSECompany Update39m ago · 26 Sept 2026, 12:02 pm
Incorporation of Royal Sandur MedTech Private Limited, Wholly Owned Subsidiary of the Company
Sandur Manganese & Iron Ores Ltd · 504918
✦ AI SummaryJoint Venture
Sandur Manganese & Iron Ores Ltd has incorporated Royal Sandur MedTech Private Limited as a wholly owned subsidiary to carry on medical devices and consumables manufacturing business. The subsidiary is 100% held by the company.
Analysis Scores
Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sandur Manganese & Iron Ores Ltd - 504918 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Attachments (1)
📄pdf
Download →
fe093a87-9d06-41ec-9b46-459a4f1bcb72.pdf
View document text
(An ISO 9001:2015; ISO 14001:2015 and ISO 45001:2018 certified company)
CIN: L85110KA1954PLC000759; Website: www.sandurgroup.com
Email ID: secretarial@sandurgroup.com
REGISTERED OFFICE CORPORATE OFFICE
‘SATYALAYA’, No.266 ‘SANDUR HOUSE’, No.9
Ward No.1, Palace Road Bellary Road, Sadashivanagar
Sandur – 583 119, Ballari District Bengaluru – 560 080
Karnataka, India Karnataka, India
Tel: 08395 260300 Tel: 080 4152 0176 - 79 / 4547 3000
SMIORE / SEC / 2026-27 / 48 26 September 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G
Dalal Street Bandra-Kurla Complex
Mumbai - 400 001 Mumbai - 400 051
Scrip Code: 504918 Symbol: SANDUMA
Symbol: SANDUMA
Dear Sir/ Madam,
Sub: Incorporation of Royal Sandur MedTech Private Limited, Wholly Owned Subsidiary of the
Company
Ref: Letter No. SMIORE / SEC / 2026-27 / 47 dated 17 September 2026 pertaining to
incorporation of Wholly Owned Subsidiary
Pursuant to Regulation 30 read with Schedule III of Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) “SEBI (LODR)” Regulations, 2015, this is to inform Stock
Exchanges that Royal Sandur MedTech Private Limited has been incorporated as a Wholly Owned
Subsidiary of the Company vide Certificate of Incorporation dated 25 September 2026, from Ministry
of Corporate Affairs, Government of India.
Detailed information as required under SEBI (LODR) Regulations, 2015 read with SEBI Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January 2026 in respect of the same is given in
‘Annexure A’ to this letter.
Stock Exchanges are requested to kindly take the same on record.
Thank you
for The Sandur Manganese & Iron Ores Limited
Neha Thomas
Company Secretary & Compliance Officer
ICSI Membership No. A60853
Encl: A/a
MINES OFFICE: Deogiri - 583112, Sandur Taluk, Ballari District; Tel: +91 8395 271028
PLANT OFFICE: Metal & Ferroalloy Plant, Vyasankere, Mariyammanahalli – 583 222, Hosapete Taluk, Vijayanagara District;
Tel: +91 8394 294802 / 805
Page 1 of 2
The Sandur Manganese & Iron Ores Limited
Annexure A
[Details as required under SEBI (LODR) Regulations, 2015 read with SEBI Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January 2026]
Name of the entity, date & Name: Royal Sandur MedTech Private Limited
country of incorporation, etc. Date of incorporation: 25 September 2026
Country of incorporation: India
Name of holding company of Holding Company: The Sandur Manganese & Iron Ores Limited
the incorporated company and Relation: Wholly Owned Subsidiary of The Sandur Manganese & Iron Ores
relation with the listed entity Limited
Industry to which the entity Medical devices and consumables manufacturing
incorporated belongs
Brief background about the Royal Sandur MedTech Private Limited is incorporated to carry on the
entity incorporated in terms of business of medical devices and consumables manufacturing including but
products/ line of business not limited to manufacturing, processing, assembling, marketing and
distribution of medical devices, surgical products, diagnostic products and
healthcare consumables.
Brief details of any Approval received from Ministry of Corporate Affairs, Government of India
governmental or regulatory vide Certificate of Incorporation dated 25 September 2026.
approvals required for the
incorporation
Nature of consideration - Subscription of equity shares in cash.
whether cash consideration or
share swap and details of the
same
Cost of subscription/ price at 10,00,000 equity shares of ₹10/- each aggregating to ₹1,00,00,000/-.
which the shares are
subscribed
Percentage of shareholding/ 100% shareholding of Royal Sandur MedTech Private Limited is held by The
control by the listed entity and/ Sandur Manganese & Iron Ores Limited.
or number of shares allotted
Page 2 of 2